{"id":2521,"date":"2023-07-28T08:39:08","date_gmt":"2023-07-28T08:39:08","guid":{"rendered":"https:\/\/newidibe.zeus.umh.es\/?page_id=2521"},"modified":"2023-08-24T19:33:01","modified_gmt":"2023-08-24T19:33:01","slug":"dr-fracisco-javier-alvarez-martinez","status":"publish","type":"page","link":"https:\/\/idibe.umh.es\/en\/dr-fracisco-javier-alvarez-martinez\/","title":{"rendered":"Dr. Francisco Javier Alvarez Martinez"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.2.2&#8243; background_color=&#8221;#ffffff&#8221; custom_padding=&#8221;16px|0px|16px|0px|false|false&#8221; border_color_top=&#8221;#AB1A2D&#8221;][et_pb_row column_structure=&#8221;1_3,2_3&#8243; _builder_version=&#8221;4.2.2&#8243; custom_padding=&#8221;11px|0px|0|0px|false|false&#8221;][et_pb_column type=&#8221;1_3&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_image src=&#8221;https:\/\/idibe.umh.es\/files\/2023\/08\/Javier-Alvarez.png&#8221; align=&#8221;center&#8221; _builder_version=&#8221;4.2.2&#8243;][\/et_pb_image][\/et_pb_column][et_pb_column type=&#8221;2_3&#8243; _builder_version=&#8221;4.2.2&#8243; custom_padding=&#8221;150px||||false|false&#8221; custom_padding_tablet=&#8221;10px||||false|false&#8221; custom_padding_phone=&#8221;&#8221; custom_padding_last_edited=&#8221;on|tablet&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_text _builder_version=&#8221;4.2.2&#8243; header_font=&#8221;||||||||&#8221; header_font_size=&#8221;55px&#8221; header_2_font=&#8221;Raleway||||||||&#8221; header_2_text_color=&#8221;#000000&#8243; header_2_font_size=&#8221;45px&#8221; header_3_font=&#8221;||||||||&#8221; header_4_font=&#8221;||||||||&#8221; header_4_text_color=&#8221;#ffffff&#8221; custom_margin=&#8221;||||false|false&#8221;]<\/p>\n<h2 style=\"text-align: center;\"><strong>Dr. Francisco Javier \u00c1lvarez Mart\u00ednez<\/strong><\/h2>\n<p>[\/et_pb_text][et_pb_text _builder_version=&#8221;4.2.2&#8243; header_font=&#8221;||||||||&#8221; header_text_color=&#8221;#c0172d&#8221; header_2_font=&#8221;||||||||&#8221; header_3_font=&#8221;||||||||&#8221; header_4_font=&#8221;|||on|||||&#8221; header_4_text_align=&#8221;center&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; custom_margin=&#8221;-31px|107px||107px||false&#8221; custom_padding=&#8221;0px||&#8221;]<\/p>\n<h4><span lang=\"ES-TRAD\">Postdoctoral Researcher,\u00a0<\/span><span>Miguel Hern\u00e1ndez University<\/span><\/h4>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; admin_label=&#8221;section&#8221; _builder_version=&#8221;4.2.2&#8243; background_color=&#8221;#ffffff&#8221; background_enable_image=&#8221;off&#8221; parallax=&#8221;on&#8221; custom_padding=&#8221;36px|0px|35px|0px|false|false&#8221;][et_pb_row column_structure=&#8221;1_3,2_3&#8243; _builder_version=&#8221;4.16&#8243;][et_pb_column type=&#8221;1_3&#8243; _builder_version=&#8221;4.16&#8243; background_color=&#8221;rgba(255,255,255,0.5)&#8221; custom_padding=&#8221;|||&#8221; custom_css_main_element=&#8221;box-shadow: 0 20px 80px rgba(50,50,93,.09);&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_blurb use_icon=&#8221;on&#8221; font_icon=&#8221;%%60%%&#8221; icon_color=&#8221;#c0172d&#8221; icon_placement=&#8221;left&#8221; disabled_on=&#8221;on|on|on&#8221; _builder_version=&#8221;4.2.2&#8243; header_font=&#8221;Josefin Sans|||on|||||&#8221; header_text_align=&#8221;left&#8221; header_text_color=&#8221;#c0172d&#8221; header_line_height=&#8221;1.2em&#8221; body_font=&#8221;||||||||&#8221; body_line_height=&#8221;1.1em&#8221; custom_padding=&#8221;20px|20px|1px|20px|false|true&#8221; disabled=&#8221;on&#8221;]<\/p>\n<p><strong>Unit<\/strong><br \/>Biosensing and biorecognition<\/p>\n<p>[\/et_pb_blurb][et_pb_blurb use_icon=&#8221;on&#8221; font_icon=&#8221;%%61%%&#8221; icon_color=&#8221;#c0172d&#8221; icon_placement=&#8221;left&#8221; disabled_on=&#8221;on|on|on&#8221; _builder_version=&#8221;4.2.2&#8243; header_font=&#8221;Josefin Sans|||on|||||&#8221; header_text_align=&#8221;left&#8221; header_text_color=&#8221;#c0172d&#8221; header_line_height=&#8221;1.2em&#8221; body_font=&#8221;||||||||&#8221; body_line_height=&#8221;1.1em&#8221; custom_margin=&#8221;-14px||&#8221; custom_padding=&#8221;0px|20px|1px|20px|false|true&#8221; disabled=&#8221;on&#8221;]<\/p>\n<p><strong>Subunit<\/strong><br \/> <span>Environmental Signaling and Disease<\/span><\/p>\n<p>[\/et_pb_blurb][et_pb_blurb use_icon=&#8221;on&#8221; font_icon=&#8221;%%259%%&#8221; icon_color=&#8221;#c0172d&#8221; icon_placement=&#8221;left&#8221; disabled_on=&#8221;on|on|on&#8221; _builder_version=&#8221;4.2.2&#8243; header_font=&#8221;Josefin Sans|||on|||||&#8221; header_text_align=&#8221;left&#8221; header_text_color=&#8221;#c0172d&#8221; header_line_height=&#8221;1.2em&#8221; body_font=&#8221;||||||||&#8221; body_line_height=&#8221;1.1em&#8221; custom_margin=&#8221;-14px||&#8221; custom_padding=&#8221;0px|20px|1px|20px|false|true&#8221; disabled=&#8221;on&#8221; locked=&#8221;off&#8221;]<\/p>\n<p><strong>Group<\/strong><br \/>Peripheral Neuropathies<\/p>\n<p>[\/et_pb_blurb][et_pb_blurb use_icon=&#8221;on&#8221; font_icon=&#8221;%%238%%&#8221; icon_color=&#8221;#c0172d&#8221; icon_placement=&#8221;left&#8221; _builder_version=&#8221;4.2.2&#8243; header_font=&#8221;Josefin Sans|||on|||||&#8221; header_text_align=&#8221;left&#8221; header_text_color=&#8221;#c0172d&#8221; header_line_height=&#8221;1.2em&#8221; body_font=&#8221;||||||||&#8221; body_line_height=&#8221;1.1em&#8221; custom_padding=&#8221;12px|20px|1px|20px|false|true&#8221;]<\/p>\n<p><a href=\"mailto:f.alvarez@umh.es\">f.alvarez@umh.es<\/a><\/p>\n<p>[\/et_pb_blurb][et_pb_blurb icon_placement=&#8221;left&#8221; _builder_version=&#8221;4.2.2&#8243; header_font=&#8221;Josefin Sans|||on|||||&#8221; header_text_align=&#8221;left&#8221; header_text_color=&#8221;#c0172d&#8221; header_line_height=&#8221;1.2em&#8221; body_font=&#8221;||||||||&#8221; body_line_height=&#8221;1.1em&#8221; custom_margin=&#8221;-14px||&#8221; custom_padding=&#8221;0px|20px|1px|3px|false|false&#8221;]<a href=\"https:\/\/www.linkedin.com\/in\/francisco-javier-alvarez-martinez\" target=\"_blank\" rel=\"noopener\"><img loading=\"lazy\" class=\"alignnone wp-image-796 size-thumbnail\" src=\"http:\/\/idibe.umh.es\/files\/2023\/03\/linkedinlogo-150x150.png\" alt=\"\" width=\"23\" height=\"68\" \/><\/a>[\/et_pb_blurb][et_pb_blurb icon_placement=&#8221;left&#8221; _builder_version=&#8221;4.2.2&#8243; header_font=&#8221;Josefin Sans|||on|||||&#8221; header_text_align=&#8221;left&#8221; header_text_color=&#8221;#c0172d&#8221; header_line_height=&#8221;1.2em&#8221; body_font=&#8221;||||||||&#8221; body_line_height=&#8221;1.1em&#8221; custom_margin=&#8221;-14px||&#8221; custom_padding=&#8221;0px|20px|1px|3px|false|false&#8221;]<a href=\"https:\/\/orcid.org\/0000-0002-5275-1282\" target=\"_blank\" rel=\"noopener noreferrer\"><img loading=\"lazy\" class=\"wp-image-3808 alignnone size-large\" src=\"http:\/\/idibe.umh.es\/files\/2022\/09\/ORCID_logo.svg_-1024x348-1.png\" alt=\"\" width=\"68\" height=\"23\" \/><\/a>[\/et_pb_blurb][et_pb_blurb icon_placement=&#8221;left&#8221; disabled_on=&#8221;on|on|on&#8221; _builder_version=&#8221;4.2.2&#8243; header_font=&#8221;Josefin Sans|||on|||||&#8221; header_text_align=&#8221;left&#8221; header_text_color=&#8221;#c0172d&#8221; header_line_height=&#8221;1.2em&#8221; body_font=&#8221;||||||||&#8221; body_line_height=&#8221;1.1em&#8221; custom_margin=&#8221;-14px||&#8221; custom_padding=&#8221;0px|20px|20px|3px|false|false&#8221; disabled=&#8221;on&#8221;]<\/p>\n<p><a href=\"https:\/\/scholar.google.es\/citations?user=U602DMAAAAAJ&amp;amp;hl=es&amp;amp;oi=ao\" target=\"_blank\" rel=\"noopener noreferrer\"><img loading=\"lazy\" class=\"wp-image-775 alignnone size-medium\" src=\"http:\/\/newidibe.zeus.umh.es\/files\/2023\/02\/Google_Scholar_logo-300x50.png\" alt=\"\" width=\"114\" height=\"19\" \/><\/a><\/p>\n<p>[\/et_pb_blurb][et_pb_blurb use_icon=&#8221;on&#8221; font_icon=&#8221;%%264%%&#8221; icon_color=&#8221;#c0172d&#8221; icon_placement=&#8221;left&#8221; disabled_on=&#8221;on|on|on&#8221; _builder_version=&#8221;4.2.2&#8243; header_font=&#8221;Josefin Sans|||on|||||&#8221; header_text_align=&#8221;left&#8221; header_text_color=&#8221;#c0172d&#8221; header_line_height=&#8221;1.2em&#8221; body_font=&#8221;||||||||&#8221; body_line_height=&#8221;1.1em&#8221; custom_margin=&#8221;-14px||||false|false&#8221; custom_padding=&#8221;0px|20px|20px|20px|false|true&#8221; disabled=&#8221;on&#8221;]<\/p>\n<p><span>+34 96 522 2002<\/span><\/p>\n<p>[\/et_pb_blurb][\/et_pb_column][et_pb_column type=&#8221;2_3&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_text _builder_version=&#8221;4.2.2&#8243; header_font=&#8221;||||||||&#8221; header_text_color=&#8221;#c0172d&#8221; header_4_font=&#8221;||||||||&#8221; header_4_text_color=&#8221;#c0172d&#8221; header_4_font_size=&#8221;25px&#8221; header_4_line_height=&#8221;1.4em&#8221;]<\/p>\n<h4>RESEARCH FIELDS<\/h4>\n<p>[\/et_pb_text][et_pb_text _builder_version=&#8221;4.2.2&#8243; text_font=&#8221;||||||||&#8221; text_text_color=&#8221;#000000&#8243; text_font_size=&#8221;15px&#8221; header_font=&#8221;||||||||&#8221; header_2_font=&#8221;||||||||&#8221; header_3_font=&#8221;||||||||&#8221; header_4_font=&#8221;||||||||&#8221; header_5_font=&#8221;||||||||&#8221; header_6_font=&#8221;||||||||&#8221; custom_margin=&#8221;-31px||0px&#8221;]<\/p>\n<ul>\n<li>\n<p><span lang=\"EN-GB\">Study and development of strategies to overcome microbial resistance mechanisms to antimicrobials.<\/span><\/p>\n<\/li>\n<li>\n<p><span lang=\"EN-GB\"><\/span><span lang=\"EN-GB\">Discovery and characterization of novel antimicrobial compounds against resistant microorganisms.<\/span><\/p>\n<\/li>\n<li>\n<p><span lang=\"EN-GB\"><\/span><span lang=\"EN-GB\">Valorization of vegetable by-products to obtain high added value molecules.<\/span><\/p>\n<\/li>\n<\/ul>\n<p>[\/et_pb_text][et_pb_toggle title=&#8221;PROFESSIONAL BACKGROUND&#8221; icon_color=&#8221;#c0172d&#8221; _builder_version=&#8221;4.2.2&#8243; title_text_color=&#8221;#c0172d&#8221; title_level=&#8221;h4&#8243; title_font=&#8221;||||||||&#8221; body_font=&#8221;||||||||&#8221; body_text_color=&#8221;#000000&#8243; background_color=&#8221;#ffffff&#8221; custom_padding=&#8221;32px|32px|32px|32px|true|true&#8221; hover_enabled=&#8221;0&#8243; border_radii=&#8221;on|3px|3px|3px|3px&#8221; border_width_all=&#8221;0px&#8221; box_shadow_style=&#8221;preset1&#8243; box_shadow_color=&#8221;rgba(153,153,153,0.14)&#8221; body_text_align=&#8221;justify&#8221;]<\/p>\n<ul>\n<li style=\"text-align: justify;\"><strong>Previous positions:<\/strong><br \/> Founder and CTO of the start-up Biopina &#8211; Biotecnolog\u00eda Industrial, S.L., 2015-2018.<br \/> Researcher with Research Initiation Grant, Miguel Hern\u00e1ndez University, 2016.<br \/> PROMETEO Project Researcher, Generalitat Valenciana, Miguel Hern\u00e1ndez University, 2017.<br \/> Predoctoral Fellowship to Support the Training of Research Staff, Miguel Hern\u00e1ndez University, 2017-2020.<br \/> Researcher at Innovation Labo Technologies, S.L., 2020-2021<br \/> Predoctoral researcher with APOTIP contract, Generalitat Valenciana, Miguel Hern\u00e1ndez University, 2021.<\/li>\n<li style=\"text-align: justify;\"><strong>Postdoctoral positions:<\/strong><br \/> Margarita Salas Postdoctoral Fellow, Alicante Health and Biomedical Research Institute, ISABIAL (2022-2023) + Department of Biochemistry, Miguel Hern\u00e1ndez University (2024).<\/li>\n<li style=\"text-align: justify;\"><strong>PhD Programme:<\/strong><br \/> <strong>PhD<\/strong> in Molecular and Cellular Biology, Institute for Research, Development and Innovation in Health Biotechnology of Elche (IDiBE), Miguel Hern\u00e1ndez University of Elche, 2021. Directors: Dr. Vicente Micol Molina and Dr. Enrique Barraj\u00f3n Catal\u00e1n.<\/li>\n<li style=\"text-align: justify;\"><strong>Degree<\/strong> in Biotechnology and Master&#8217;s Degree in Biotechnology and Bioengineering.<\/li>\n<\/ul>\n<p>[\/et_pb_toggle][\/et_pb_column][\/et_pb_row][et_pb_row disabled_on=&#8221;on|on|on&#8221; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;30.375px|0px|0|0px|false|false&#8221; disabled=&#8221;on&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; header_font=&#8221;||||||||&#8221; header_text_color=&#8221;#c0172d&#8221; header_3_font=&#8221;||||||||&#8221; header_4_font=&#8221;||||||||&#8221; header_4_text_color=&#8221;#c0172d&#8221; header_4_font_size=&#8221;26px&#8221; header_4_line_height=&#8221;1.4em&#8221; custom_margin=&#8221;||8px&#8221; custom_padding=&#8221;0px|0px|0px|0px|false|true&#8221;]<\/p>\n<h4>REPRESENTATIVE PUBLICATIONS<\/h4>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; make_equal=&#8221;on&#8221; disabled_on=&#8221;on|on|on&#8221; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;15px|0px|15px|0px|true|false&#8221; custom_width_px=&#8221;1669px&#8221; disabled=&#8221;on&#8221;][et_pb_column type=&#8221;1_2&#8243; module_class=&#8221;hover_blurb&#8221; _builder_version=&#8221;4.16&#8243; background_color=&#8221;rgba(255,255,255,0.5)&#8221; custom_padding=&#8221;|||&#8221; custom_css_main_element=&#8221;box-shadow: 0 20px 80px rgba(50,50,93,.09);&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_blurb title=&#8221;DEVESA, I., ET AL. (2014)&#8221; _builder_version=&#8221;4.2.2&#8243; header_font=&#8221;Josefin Sans|||on|||||&#8221; header_text_align=&#8221;left&#8221; header_text_color=&#8221;#c0172d&#8221; header_line_height=&#8221;1.2em&#8221; body_font=&#8221;||||||||&#8221; body_line_height=&#8221;1.1em&#8221; custom_padding=&#8221;25px|25px|25px|25px|true&#8221; locked=&#8221;off&#8221;]<\/p>\n<p>Proceedings of the National Academy of Sciences of the United States of America, DOI:<span>\u00a0<\/span><a href=\"https:\/\/doi.org\/10.1073\/pnas.1420252111\" target=\"_blank\" rel=\"noopener noreferrer\">10.1073\/pnas.1420252111<\/a><\/p>\n<p><span><em>Alpha-CGRP is essential for pro-algesic sensitization of TRPV1 in peptidergic C-type nociceptors.<\/em><\/span><\/p>\n<p>[\/et_pb_blurb][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; module_class=&#8221;hover_blurb&#8221; _builder_version=&#8221;4.16&#8243; background_color=&#8221;rgba(255,255,255,0.5)&#8221; custom_padding=&#8221;|||&#8221; custom_css_main_element=&#8221;box-shadow: 0 20px 80px rgba(50,50,93,.09);&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_blurb title=&#8221;TABERNER, F., ET AL. (2014)&#8221; _builder_version=&#8221;4.2.2&#8243; header_font=&#8221;Josefin Sans|||on|||||&#8221; header_text_align=&#8221;left&#8221; header_text_color=&#8221;#c0172d&#8221; header_line_height=&#8221;1.2em&#8221; body_font=&#8221;||||||||&#8221; body_line_height=&#8221;1.1em&#8221; custom_padding=&#8221;25px|25px|25px|25px|true&#8221; locked=&#8221;off&#8221;]<\/p>\n<p><span>The Journal of Biological Chemistry<\/span>, DOI:<span>\u00a0<\/span><a href=\"https:\/\/doi.org\/10.1074\/jbc.M114.577478\" target=\"_blank\" rel=\"noopener noreferrer\">10.1074\/jbc.M114.577478<\/a><\/p>\n<p><em>The region adjacent to the C-end of the inner gate in transient receptor potential melastatin 8 (TRPM8) channels plays a central role in allosteric channel activation<\/em><\/p>\n<p>[\/et_pb_blurb][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; make_equal=&#8221;on&#8221; disabled_on=&#8221;on|on|on&#8221; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;15px|0px|15px|0px|true|false&#8221; custom_width_px=&#8221;1669px&#8221; disabled=&#8221;on&#8221;][et_pb_column type=&#8221;1_2&#8243; module_class=&#8221;hover_blurb&#8221; _builder_version=&#8221;4.16&#8243; background_color=&#8221;rgba(255,255,255,0.5)&#8221; custom_padding=&#8221;|||&#8221; custom_css_main_element=&#8221;box-shadow: 0 20px 80px rgba(50,50,93,.09);&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_blurb title=&#8221;BONACHE, M.A., ET AL. (2014)&#8221; _builder_version=&#8221;4.2.2&#8243; header_font=&#8221;Josefin Sans|||on|||||&#8221; header_text_align=&#8221;left&#8221; header_text_color=&#8221;#c0172d&#8221; header_line_height=&#8221;1.2em&#8221; body_font=&#8221;||||||||&#8221; body_line_height=&#8221;1.3em&#8221; custom_padding=&#8221;25px|25px|25px|25px|true&#8221; locked=&#8221;off&#8221;]<\/p>\n<p>ACS Combinatorial Science, DOI:\u00a0<a href=\"https:\/\/doi.org\/10.1021\/co500005x\" target=\"_blank\" rel=\"noopener noreferrer\">10.1021\/co500005x<\/a><\/p>\n<p><span><em>De novo design, synthesis, structure and validation of a library of helical peptides for modulation of protein-protein interactions.<\/em><\/span><\/p>\n<p>[\/et_pb_blurb][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; module_class=&#8221;hover_blurb&#8221; _builder_version=&#8221;4.16&#8243; background_color=&#8221;rgba(255,255,255,0.5)&#8221; custom_padding=&#8221;|||&#8221; custom_css_main_element=&#8221;box-shadow: 0 20px 80px rgba(50,50,93,.09);&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_blurb title=&#8221;GREGORIO-TERUEL, L., ET AL. (2014)&#8221; _builder_version=&#8221;4.2.2&#8243; header_font=&#8221;Josefin Sans|||on|||||&#8221; header_text_align=&#8221;left&#8221; header_text_color=&#8221;#c0172d&#8221; header_line_height=&#8221;1.2em&#8221; body_font=&#8221;||||||||&#8221; body_line_height=&#8221;1.1em&#8221; custom_padding=&#8221;25px|25px|25px|25px|true&#8221; locked=&#8221;off&#8221;]<\/p>\n<p>The Journal of General Physiology, DOI:<a href=\"https:\/\/doi.org\/10.1085\/jgp.201311070\" target=\"_blank\" rel=\"noopener noreferrer\">10.1085\/jgp.201311070<\/a><\/p>\n<p><em><span>Mutation of I696 and W697 in the trp box of vanilloid receptor subtype modulate allosteric channel activation<\/span><\/em><\/p>\n<p>[\/et_pb_blurb][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; make_equal=&#8221;on&#8221; disabled_on=&#8221;on|on|on&#8221; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;15px|0px|15px|0px|true|false&#8221; custom_width_px=&#8221;1669px&#8221; disabled=&#8221;on&#8221;][et_pb_column type=&#8221;1_2&#8243; module_class=&#8221;hover_blurb&#8221; _builder_version=&#8221;4.16&#8243; background_color=&#8221;rgba(255,255,255,0.5)&#8221; custom_padding=&#8221;|||&#8221; custom_css_main_element=&#8221;box-shadow: 0 20px 80px rgba(50,50,93,.09);&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_blurb title=&#8221;DEVESA I. AND FERRER-MONTIEL A. (2014)&#8221; _builder_version=&#8221;4.2.2&#8243; header_font=&#8221;Josefin Sans|||on|||||&#8221; header_text_align=&#8221;left&#8221; header_text_color=&#8221;#c0172d&#8221; header_line_height=&#8221;1.2em&#8221; body_font=&#8221;||||||||&#8221; body_line_height=&#8221;1.3em&#8221; custom_padding=&#8221;25px|25px|25px|25px|true&#8221; locked=&#8221;off&#8221;]<\/p>\n<p>The European Journal of Neuroscience, DOI:<span>\u00a0<\/span><a href=\"https:\/\/doi.org\/10.1111\/ejn.12455\" target=\"_blank\" rel=\"noopener noreferrer\">10.1111\/ejn.12455<\/a><\/p>\n<p><span><em>Neurotrophins, endocannabinoids and thermoTRPs: a threesome in pain signalings.<\/em><\/span><\/p>\n<p>[\/et_pb_blurb][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; module_class=&#8221;hover_blurb&#8221; _builder_version=&#8221;4.16&#8243; background_color=&#8221;rgba(255,255,255,0.5)&#8221; custom_padding=&#8221;|||&#8221; custom_css_main_element=&#8221;box-shadow: 0 20px 80px rgba(50,50,93,.09);&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_blurb _builder_version=&#8221;4.2.2&#8243; header_font=&#8221;Josefin Sans|||on|||||&#8221; header_text_align=&#8221;left&#8221; header_text_color=&#8221;#c0172d&#8221; header_line_height=&#8221;1.2em&#8221; body_font=&#8221;||||||||&#8221; body_line_height=&#8221;1.3em&#8221; custom_padding=&#8221;25px|25px|25px|25px|true&#8221; locked=&#8221;off&#8221;][\/et_pb_blurb][\/et_pb_column][\/et_pb_row][et_pb_row disabled_on=&#8221;on|on|on&#8221; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;30.375px|0px|0|0px|false|false&#8221; disabled=&#8221;on&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; header_font=&#8221;||||||||&#8221; header_text_color=&#8221;#c0172d&#8221; header_3_font=&#8221;||||||||&#8221; header_4_font=&#8221;||||||||&#8221; header_4_text_color=&#8221;#c0172d&#8221; header_4_font_size=&#8221;26px&#8221; header_4_line_height=&#8221;1.4em&#8221; custom_margin=&#8221;||8px&#8221; custom_padding=&#8221;0px|0px|0px|0px|false|true&#8221;]<\/p>\n<h4>PATENTS AND AVAILABLE TECHNOLOGIES<\/h4>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; make_equal=&#8221;on&#8221; disabled_on=&#8221;on|on|on&#8221; _builder_version=&#8221;4.2.2&#8243; custom_padding=&#8221;15px|0px|15px|0px|true|false&#8221; custom_width_px=&#8221;1669px&#8221; disabled=&#8221;on&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; background_color=&#8221;rgba(255,255,255,0.5)&#8221; custom_padding=&#8221;|||&#8221; custom_css_main_element=&#8221;box-shadow: 0 20px 80px rgba(50,50,93,.09);&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_blurb title=&#8221;NEURONAL EXOCYTOSIS INHIBITING PEPTIDE AND COSMETIC COMPOSITION AND PHARMACEUTICAL COMPOSITION CONTAINING THE PEPTIDE&#8221; _builder_version=&#8221;4.2.2&#8243; header_font=&#8221;Josefin Sans|||on|||||&#8221; header_text_align=&#8221;left&#8221; header_text_color=&#8221;#c0172d&#8221; header_line_height=&#8221;1.2em&#8221; body_font=&#8221;||||||||&#8221; body_line_height=&#8221;1.6em&#8221; custom_padding=&#8221;25px|25px|25px|25px|true&#8221;]<\/p>\n<p style=\"text-align: left;\"><strong>Inventores:<\/strong><span>\u00a0Blanes C, Llobregat M, Gil A, Fern\u00e1ndez-Ballester G, Planells Cases R, Viniegra S, Gutierrez LM, Carbonell T, P\u00e9rez-Pay\u00e1 E, Ferrer-Montiel. A.<\/span><br \/><strong>N\u00ba :<\/strong><span>\u00a0ES2160482 B1 (granted on 18\/04\/2002); EP1180524 B1 (granted on 30\/08\/2006); CA2370289 A1; US7015192 B1 (granted on 21\/03\/2006); US77473679 B1 (granted on 21\/03\/2006).<\/span><\/p>\n<p>[\/et_pb_blurb][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; background_color=&#8221;rgba(255,255,255,0.5)&#8221; custom_padding=&#8221;|||&#8221; custom_css_main_element=&#8221;box-shadow: 0 20px 80px rgba(50,50,93,.09);&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_blurb title=&#8221;N-ALKYLGLYCINE TRIMERES CAPABLE OF BLOCKING THE RESPONSE TO CHEMICAL SUBSTANCES, THERMAL STIMULI OR MEDIATORS OF NEURONAL RECEPTOR INFLAMMATION AND COMPOSITIONS CONTAINING SAID TRIMERES&#8221; _builder_version=&#8221;4.2.2&#8243; header_font=&#8221;Josefin Sans|||on|||||&#8221; header_text_align=&#8221;left&#8221; header_text_color=&#8221;#c0172d&#8221; header_line_height=&#8221;1.2em&#8221; body_font=&#8221;||||||||&#8221; body_line_height=&#8221;1.6em&#8221; custom_padding=&#8221;25px|25px|25px|25px|true&#8221;]<\/p>\n<p style=\"text-align: left;\"><strong>Inventores:<\/strong><span>\u00a0Antonio Ferrer Montiel, Asia Fern\u00e1ndez Carvajal, Carolina Garc\u00eda Mart\u00ednez, Carlos Belmonte Mart\u00ednez, Wim van den Nest, Cristina Carre\u00f1o Serraima.<\/span><br \/><strong>N\u00ba:<\/strong><span>\u00a0ES2169691 B1 (granted on 16\/03\/2004); WO02\/30956; EP1338605 A1; US2004\/33958; AU9388201; BR200114802 A; CA2425520 A1; JP2004\/511491; MX PA\/a\/03003158.<\/span><\/p>\n<p>[\/et_pb_blurb][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; make_equal=&#8221;on&#8221; disabled_on=&#8221;on|on|on&#8221; _builder_version=&#8221;4.2.2&#8243; custom_padding=&#8221;15px|0px|15px|0px|true|false&#8221; custom_width_px=&#8221;1669px&#8221; disabled=&#8221;on&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; background_color=&#8221;rgba(255,255,255,0.5)&#8221; custom_padding=&#8221;|||&#8221; custom_css_main_element=&#8221;box-shadow: 0 20px 80px rgba(50,50,93,.09);&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_blurb title=&#8221;N-ALKYLGLYCINE TRIMERES CAPABLE OF PROTECTING NEURONS AGAINST EXCITOTOXIC AGGRESSIONS AND COMPOSITIONS CONTAINING SUCH TRIMERES&#8221; _builder_version=&#8221;4.2.2&#8243; header_font=&#8221;Josefin Sans|||on|||||&#8221; header_text_align=&#8221;left&#8221; header_text_color=&#8221;#c0172d&#8221; header_line_height=&#8221;1.2em&#8221; body_font=&#8221;||||||||&#8221; body_line_height=&#8221;1.6em&#8221; custom_padding=&#8221;25px|25px|25px|25px|true&#8221;]<\/p>\n<p style=\"text-align: left;\"><strong>Inventores:<\/strong><span>\u00a0Felipo V, Montoliu C, Planells Cases R, Merino J, P\u00e9rez-Pay\u00e1 E, S\u00e1nchez-Baeza F, Humet M, Messeguer A, Ferrer-Montiel, A.<\/span><br \/><strong>N\u00ba :<\/strong><span>\u00a0ES2169690 B1 (granted on 16\/03\/2004); ES2267816 T3 (granted on 16\/03\/2007); WO02\/28885; EP1338604 B1 (granted on 12\/07\/2006); US6992064 B1 (granted on 31\/01\/2006); AU2001291906 A; BRPI0114660 A; CA2427072 A1; JP2002-532467; KR 849739 (granted on 01\/08\/2008); MX244057 B (granted on 09\/03\/2007).<\/span><\/p>\n<p>[\/et_pb_blurb][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; background_color=&#8221;rgba(255,255,255,0.5)&#8221; custom_padding=&#8221;|||&#8221; custom_css_main_element=&#8221;box-shadow: 0 20px 80px rgba(50,50,93,.09);&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_blurb title=&#8221;COMPOUNDS WHICH CAN BLOCK THE RESPONSES TO CHEMICAL SUBSTANCES OR THERMAL STIMULI OR MEDIATORS OF INFLAMMATION OF NOCICEPTORS, PRODUCTION METHOD THEREOF AND COMPOSITIONS CONTAINING SAME&#8221; _builder_version=&#8221;4.2.2&#8243; header_font=&#8221;Josefin Sans|||on|||||&#8221; header_text_align=&#8221;left&#8221; header_text_color=&#8221;#c0172d&#8221; header_line_height=&#8221;1.2em&#8221; body_font=&#8221;||||||||&#8221; body_line_height=&#8221;1.6em&#8221; custom_padding=&#8221;25px|25px|25px|25px|true&#8221;]<\/p>\n<p style=\"text-align: left;\"><strong>Inventores:<\/strong><span>\u00a0Fern\u00e1ndez-Carvajal A, Garc\u00eda-Mart\u00ednez C, Belmonte C, Van Den Nest W, Carre\u00f1o C., Ferrer-Montiel A.<\/span><br \/><strong>N\u00ba:<\/strong><span>\u00a0ES2195787 B1 (granted on 01\/06\/2005); WO03\/097670; EP1506970 A1; US7183430 B2 (granted on 27\/02\/2003); AU2003\/231331; CA2486342 A1; JP2006\/502975 ; MX PA\/a\/04011502.<\/span><\/p>\n<p>[\/et_pb_blurb][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; make_equal=&#8221;on&#8221; disabled_on=&#8221;on|on|on&#8221; _builder_version=&#8221;4.2.2&#8243; custom_padding=&#8221;15px|0px|15px|0px|true|false&#8221; custom_width_px=&#8221;1669px&#8221; disabled=&#8221;on&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; background_color=&#8221;rgba(255,255,255,0.5)&#8221; custom_padding=&#8221;|||&#8221; custom_css_main_element=&#8221;box-shadow: 0 20px 80px rgba(50,50,93,.09);&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_blurb title=&#8221;DERMOPHARMACEUTICAL OR COSMETIC COMPOSITION COMPRISING ENKEPHALINE-DERIVED PEPTIDES FOR REDUCING AND\/OR ELIMINATING FACIAL WRINKLES&#8221; _builder_version=&#8221;4.2.2&#8243; header_font=&#8221;Josefin Sans|||on|||||&#8221; header_text_align=&#8221;left&#8221; header_text_color=&#8221;#c0172d&#8221; header_line_height=&#8221;1.2em&#8221; body_font=&#8221;||||||||&#8221; body_line_height=&#8221;1.6em&#8221; custom_padding=&#8221;25px|25px|25px|25px|true&#8221;]<\/p>\n<p style=\"text-align: left;\"><span><strong>Inventores:<\/strong>\u00a0Ferrer-Montiel A, Cebri\u00e1n J, Puig A.<br \/><strong>N\u00ba:<\/strong>\u00a0ES2259928 B1 (granted on 06\/09\/2007); WO2006\/106164; EP1892247 A1; US11\/910719; AU2006231273; BR 0609745-6; CA2608165 A1; JP2008-504786; MX PA\/a\/2007012504.<\/span><span>\u00a0<\/span><\/p>\n<p>[\/et_pb_blurb][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.2.2&#8243;][\/et_pb_column][\/et_pb_row][et_pb_row disabled_on=&#8221;on|on|on&#8221; _builder_version=&#8221;4.2.2&#8243; disabled=&#8221;on&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.2.2&#8243;][et_pb_text _builder_version=&#8221;4.2.2&#8243; header_font=&#8221;||||||||&#8221; header_text_color=&#8221;#c0172d&#8221; header_3_font=&#8221;||||||||&#8221; header_4_font=&#8221;||||||||&#8221; header_4_text_color=&#8221;#c0172d&#8221; header_4_font_size=&#8221;26px&#8221; header_4_line_height=&#8221;1.4em&#8221; custom_margin=&#8221;||8px&#8221; custom_padding=&#8221;0px|0px|0px|0px|false|true&#8221;]<\/p>\n<h4>COMPANY AGREEMENTS<\/h4>\n<p>[\/et_pb_text][et_pb_text _builder_version=&#8221;4.2.2&#8243; text_text_color=&#8221;#000000&#8243; header_font=&#8221;||||||||&#8221; header_text_color=&#8221;#c0172d&#8221; header_3_font=&#8221;||||||||&#8221; header_4_font=&#8221;||||||||&#8221; header_4_text_color=&#8221;#c0172d&#8221; header_4_font_size=&#8221;26px&#8221; header_4_line_height=&#8221;1.4em&#8221; custom_margin=&#8221;||8px&#8221; custom_padding=&#8221;0px|0px|0px|0px|false|true&#8221;]<\/p>\n<ul>\n<li><span>BCN Peptides<\/span><\/li>\n<li><span>DiverDrugs<\/span><\/li>\n<\/ul>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dr. Francisco Javier \u00c1lvarez Mart\u00ednezPostdoctoral Researcher,\u00a0Miguel Hern\u00e1ndez University &nbsp;UnitBiosensing and biorecognitionSubunit Environmental Signaling and DiseaseGroupPeripheral Neuropathiesf.alvarez@umh.es+34 96 522 2002RESEARCH FIELDS Study and development of strategies to overcome microbial resistance mechanisms to antimicrobials. Discovery and characterization of novel antimicrobial compounds against resistant microorganisms. Valorization of vegetable by-products to obtain high added value molecules. Previous positions: Founder [&hellip;]<\/p>\n","protected":false},"author":1159,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","_links_to":"","_links_to_target":""},"_links":{"self":[{"href":"https:\/\/idibe.umh.es\/en\/wp-json\/wp\/v2\/pages\/2521"}],"collection":[{"href":"https:\/\/idibe.umh.es\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/idibe.umh.es\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/idibe.umh.es\/en\/wp-json\/wp\/v2\/users\/1159"}],"replies":[{"embeddable":true,"href":"https:\/\/idibe.umh.es\/en\/wp-json\/wp\/v2\/comments?post=2521"}],"version-history":[{"count":0,"href":"https:\/\/idibe.umh.es\/en\/wp-json\/wp\/v2\/pages\/2521\/revisions"}],"wp:attachment":[{"href":"https:\/\/idibe.umh.es\/en\/wp-json\/wp\/v2\/media?parent=2521"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}